
A cheap and easy-to-use device has been developed by scientists to detect cancer in ten minutes.
Jonathan O'Halloran created the iPhone-sized Q-POC, which is also able to analyse disease's genetic signatures before advising on the best type of drugs that can be used for treatment, the Daily Express reported.
Advertisement
The first prototypes of the device are undergoing trials and according to experts has the potential to prolong the lives of 12.7million newly-diagnosed cancer sufferers and save lives of millions.
O'Halloran, 37, said that the team is using the device - that he developed while he was experimenting in his garage - to extract, amplify and analyse DNA from tumours or other samples to make sure that the patient gets a personalised service as soon as possible.
He asserted that the device can also provide rapid diagnosis for TB, malaria, HIV and STIs.
The device analyses submicroscopic amounts of human tissue to diagnose a disease or cancer by its genetic make-up and how far it has progressed.
Source: ANI
He asserted that the device can also provide rapid diagnosis for TB, malaria, HIV and STIs.
The device analyses submicroscopic amounts of human tissue to diagnose a disease or cancer by its genetic make-up and how far it has progressed.
Source: ANI
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Cancer News

The combination of the personalized cancer vaccine with ACT led to ovarian cancer control in few patients within a span of three months, stated study results.

Uncovering key kinases in tumor growth and invasion is crucial for improving targeted therapies in advanced-stage colorectal cancer.

The study findings validate metal-enhanced photo-oxidation for future metal-based anticancer drugs.

Mutations in 11 genes are linked to aggressive forms of prostate cancer, which may present novel therapeutic and therapy options.

Improved oral health, as indicated by the count of natural teeth and dental appointments preceding the diagnosis, correlated with enhanced head and neck cancer survival rates.